Long-term Follow-up of Acid Violet 17 Damage to the Retinal Pigment Epithelium and Retina after Macular Hole Surgery

Abstract

Background Acid violet 17 (1.5 mg/ml, ala purple) was CE approved as a dye to stain the internal limiting membrane during vitreoretinal interventions. The product was later withdrawn from the market due to safety concerns. This report describes the long-term follow-up in two eyes with obvious toxic effects caused by the dye after macular hole (MH) surgery. Methods The clinical report on pre- and postoperative findings, including SD-OCT, and functional results are presented. Results Preoperative visual acuity (Snellen) was 0.2 p in patient 1 (P1, male 73 years), and 0.1 p in patient 2 (P2, male 78 years). The preoperative horizontal basal diameter of the hole was 1190 µm in P1, and 638 µm in P2. The minimum horizontal diameters of the MHs were 475 µm (P1) and 338 µm (P2). Both MHs were successfully closed. At 10 (P1) and 18 days (P2) after surgery, the patients presented with central destruction of the RPE and associated photoreceptor layer. Visual acuity decreased to hand movements at 2 metres (P1) and 0.05 (P2). In P1, initial swelling of the retinal nerve fibre layer (RNFL) was observed, followed by attenuation to below the preoperative level. In both patients, the central area of degeneration expanded continuously until the end of follow-up (P1: 7.8, P2: 7.25 years). Final visual acuity was 0.05 in P1, and finger counting at 1 metre in P2. Conclusions The cases presented here exemplify the potential severity of acid violet 17 damage after macular hole surgery.

Publikationsverlauf

Eingereicht: 25. September 2023

Angenommen: 11. Oktober 2023

Artikel online veröffentlicht:
23. April 2024

• References

• 1 Bergamo VC, Caiado RR, Maia A. et al. Role of Vital Dyes in Chromvitrectomy. Asia Pac J Ophthalmol 2020; 24: 26-38
• 2 Gerding H. Intravital staining of the internal limiting membrane with a novel heavy solution of brilliant blue G. Klin Monbl Augenheilkd 2011; 228: 298-301
• 3 Steel DHW, Karimi AA, White K. An evaluation of two heavier-than-water internal limiting membrane-specific dyes during macular hole surgery. Graefes Arch Clin Exp Ophthalmol 2016; 254: 1289-1295
• 4 Gerding H. Acid Violet 17: a New Dye for Chromovitrectomy?. Klin Monbl Augenheilkd 2016; 233: 460-464
• 5 Röhrig S, Farecki ML, Boden KT. et al. Negative effects of vital dyes after uneventful vitreomacular surgery. Retina 2019; 39: 1772-1778
• 6 Gerding H. Intraocular use of acid violet 17 at a concentration of 1.5 mg/ml is not safe. Graefes Arch Clin Exp Ophthalmol 2017; 255: 627-628
• 7 Hurst J, Schnichels S, Spitzer MS. et al. Negative Effects of Violet-17 and MBB Dual In Vitro on Different Ocular Cell Lines. Curr Eye Res 2017; 42: 1209-1214
• 8 Council of Europe. Resolution ResAP(2008)1 on requirements and criteria for the safety of tattoos and permanent make up. Accessed November 14, 2023 at: https://search.coe.int/cm/Pages/result_details.aspx?Objectld_09000016805d3dc4
• 9 Gerding H, Kolck A. Perfluorohexyloctane as internal tamponade in patients with complicated retinal detachment. Results after 6 months. Ophthalmologe 2004; 101: 255-262
• 10 Pastor JC, Coco RM, Fernandez-Bueno I. et al. Acute retinal damage after using a toxic perfluoro-octane for vitreo-retinal surgery. Retina 2017; 37: 1140-1151